NovoCure

(NASDAQ) NVCR

Current Price$17.93

Market Cap$2.07B

Since IPO (2015)-2%

5 Year-91%

1 Year+3%

1 Month+66%

NovoCure Financials at a Glance

Market Cap

$2.07B

Revenue (TTM)

$674.41M

Net Income (TTM)

$173.05M

EPS (TTM)

$-1.53

P/E Ratio

-11.66

Dividend

$0.00

Beta (Volatility)

1.46 (Average)

Dividend

$0.00

Beta (Volatility)

1.46 (Average)

Price

$17.93

Volume

2,377,008.586

Open

$16.90

Price

$17.93

Volume

2,377,008.586

Open

$16.90

Previous Close

$17.89

Daily Range

$16.85 - $18.19

52-Week Range

$9.82 - $20.06

Dividend

$0.00

Beta (Volatility)

1.46 (Average)

Price

$17.93

Volume

2,377,008.586

Open

$16.90

Previous Close

$17.89

Daily Range

$16.85 - $18.19

52-Week Range

$9.82 - $20.06

NVCR News

1 Stock Down 35% This Year You'll Regret Not Buying on the Dip, According to Wall Street

Prosper Junior BakinyMay 28, 2025

Why NovoCure Stock Skyrocketed This Week

Johnny RiceApr 25, 2025

Person in a lab gazing into a microscope

Why NovoCure Stock Leaped 4% Higher Today

Eric VolkmanApr 24, 2025

NovoCure Surpasses Q1 Expectations

Motley Fool Markets TeamApr 24, 2025

Why NovoCure Stock Was Withering on Wednesday

Eric VolkmanApr 16, 2025

Page 1

NVCR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NovoCure

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

1,605

CEO

Frank Leonard

Website

www.novocure.com

Headquarters

Saint Helier, JE2 4UF, JE

NVCR Financials

Key Financial Metrics (TTM)

Gross Margin

75%

Operating Margin

-27%

Net Income Margin

-26%

Return on Equity

-50%

Return on Capital

-32%

Return on Assets

-22%

Earnings Yield

-8.58%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.07B

Shares Outstanding

115.82M

Volume

2.38M

Avg. Volume

2.00M

Financials (TTM)

Gross Profit

$488.47M

Operating Income

$153.80M

EBITDA

$119.05M

Operating Cash Flow

$49.03M

Capital Expenditure

$26.65M

Free Cash Flow

$75.68M

Cash & ST Invst.

$457.52M

Total Debt

$290.00M

NovoCure Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$174.06M

+12.3%

Gross Profit

$135.13M

+16.0%

Gross Margin

77.63%

N/A

Market Cap

$2.07B

N/A

Market Cap/Employee

$1.39M

N/A

Employees

1,488

N/A

Net Income

$71.14M

-107.3%

EBITDA

$63.30M

-83.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$206.86M

-11.8%

Accounts Receivable

$93.27M

-21.3%

Inventory

$43.46M

+10.1%

Long Term Debt

$234.94M

+70.5%

Short Term Debt

$0.00

-100.0%

Return on Assets

-21.96%

N/A

Return on Invested Capital

-32.15%

N/A

Free Cash Flow

$18.67M

+59.7%

Operating Cash Flow

$13.52M

+62.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ESTAEstablishment Labs Holdings Inc.

ESTAEstablishment Labs Holdings Inc.$71.77-0.36%

NEOGNeogen Corporation

NEOGNeogen Corporation$9.05-2.16%

STAASTAAR Surgical Company

STAASTAAR Surgical Company$26.69-2.16%

TDOCTeladoc Health, Inc.

TDOCTeladoc Health, Inc.$7.25+4.15%

PLSEPulse Biosciences, Inc.

PLSEPulse Biosciences, Inc.$19.08-2.60%

KMTSKestra Medical Technologies, Ltd.

KMTSKestra Medical Technologies, Ltd.$21.05-2.18%

EVOEvotec SE

EVOEvotec SE$3.07+0.66%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

NOKNokia

NOKNokia$12.82+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.35+0.01%

BBBlackBerry

BBBlackBerry$6.37+0.04%

Questions About NVCR

What is the current price of NovoCure?

NovoCure is trading at $17.89 per share.

What is the 52-week range for NovoCure?

Over the past 52 weeks, NovoCure has traded between $9.82 and $20.06.

How much debt does NovoCure have?

As of the most recent reporting period, NovoCure reported total debt of $234.94M.

How much cash does NovoCure have on hand?

NovoCure reported $97.32M in cash and cash equivalents in its most recent financial results.

What is NovoCure’s dividend yield?

NovoCure does not currently have a dividend yield.

NovoCure

NovoCure Financials at a Glance

NVCR News

2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon

NovoCure Q2 Revenue Jumps 6 Percent

Novocure: Steady Ahead of Key Milestones

1 Stock Down 35% This Year You'll Regret Not Buying on the Dip, According to Wall Street

Why NovoCure Stock Skyrocketed This Week

Why NovoCure Stock Leaped 4% Higher Today

NovoCure Surpasses Q1 Expectations

Why NovoCure Stock Was Withering on Wednesday

NVCR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NovoCure

NVCR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NovoCure Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NVCR

What is the current price of NovoCure?

What is the 52-week range for NovoCure?

How much debt does NovoCure have?

How much cash does NovoCure have on hand?

What is NovoCure’s dividend yield?

Premium Investing Services